Anti-Ro52 Autoantibody Is Common in Systemic Autoimmune Rheumatic Diseases and Correlating with Worse Outcome when Associated with interstitial lung disease in Systemic Sclerosis and Autoimmune Myositis-Reference-Cited by-同舟云学术

Anti-Ro52 Autoantibody Is Common in Systemic Autoimmune Rheumatic Diseases and Correlating with Worse Outcome when Associated with interstitial lung disease in Systemic Sclerosis and Autoimmune Myositis

Published:2022-01-18 Issue:2 Volume:63 Page:178-193
ISSN:1559-0267
Container-title:Clinical Reviews in Allergy & Immunology
language:en
Short-container-title:Clinic Rev Allerg Immunol

Author:

Chan Edward K. L.

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Immunology and Allergy

Link

https://link.springer.com/content/pdf/10.1007/s12016-021-08911-z.pdf

Reference111 articles.

1. Lee AYS (2017) A review of the role and clinical utility of anti-Ro52/TRIM21 in systemic autoimmunity. Rheumatol Int 45(1):183–191

2. Oke V, Wahren-Herlenius M (2012) The immunobiology of Ro52 (TRIM21) in autoimmunity: a critical review. J Autoimmun 39(1–2):77–82

3. Clark G, Reichlin M, Tomasi TB Jr (1969) Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythmatosus. J Immunol 102(1):117–122

4. Tan EM, Kunkel HG (1966) Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus. J Immunol 96(3):464–471

5. Alspaugh MA, Tan EM (1975) Antibodies to cellular antigens in Sjogren’s syndrome. J Clin Invest 55(5):1067–1073

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarkers reflecting the pathogenesis, clinical manifestations, and guide therapeutic approach in systemic sclerosis: a narrative review;Clinical Rheumatology;2024-08-29

2. Association of anti-Ro-52 antibodies with occurrence of interstitial lung disease in patients with idiopathic inflammatory myopathy;Arthritis Research & Therapy;2024-08-22

3. Impact of sex differences on the clinical presentation, pathogenesis, treatment and prognosis of Sjögren's syndrome;Immunology;2023-12-29

4. Prevalence of anti-synthetase antibodies among systemic sclerosis patients;European Journal of Internal Medicine;2023-11

5. Ro52/TRIM21 – From host defense to autoimmunity;Cellular Immunology;2023-11